This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

ABX464

Abivax S.A.

Drug Names(s): ABX464

Description: ABX464 is a novel, small molecule inhibiting the biogenesis of viral RNA required for the replication of the HIV virus. In pre-clinical reference models of HIV, ABX464 was able to induce a substantial reduction in viral load that persists for weeks after treatment arrest.


ABX464 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug